4880.T
Price:
$320
Market Cap:
$6.35B
CellSource Co., Ltd. operates within both the regenerative medicine and consumer product sectors. Among its offerings is Signalift, an anti-aging solution. The company, which was established in 2015, is headquartered in Tokyo, Japan.
Industry
Biotechnology
IPO Date
2019-10-29
Stock Exchange
JPX
Ticker
4880.T
According to CellSource Co., Ltd.’s latest financial reports and current stock price. The company's current PE Ratio is 89.66. This represents a change of 198.18% compared to the average of 30.07 of the last 4 quarters.
The mean historical PE Ratio of CellSource Co., Ltd. over the last ten years is 199.09. The current 89.66 PE Ratio has changed 4.40% with respect to the historical average. Over the past ten years (40 quarters), 4880.T's PE Ratio was at its highest in in the July 2020 quarter at 266.31. The PE Ratio was at its lowest in in the January 2025 quarter at -92.28.
Average
199.09
Median
98.75
Minimum
36.48
Maximum
935.19
Discovering the peaks and valleys of CellSource Co., Ltd. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 847.00%
Maximum Annual PE Ratio = 935.19
Minimum Annual Increase = -56.53%
Minimum Annual PE Ratio = 36.48
| Year | PE Ratio | Change |
|---|---|---|
| 2025 | 935.19 | 847.00% |
| 2024 | 98.75 | 170.72% |
| 2023 | 36.48 | -54.73% |
| 2022 | 80.58 | -56.53% |
| 2021 | 185.39 | -0.61% |
| 2020 | 186.53 | 138.20% |
| 2019 | 78.31 | 12.34% |
| 2018 | 69.71 | -42.36% |
The current PE Ratio of CellSource Co., Ltd. (4880.T) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
356.80
5-year avg
267.28
10-year avg
199.09
CellSource Co., Ltd.’s PE Ratio is greater than Stella Pharma Corporation (-13.73), greater than MEDINET Co., Ltd. (-5.51), greater than MediciNova, Inc. (-5.72), greater than Chiome Bioscience Inc. (-5.05), greater than NANO MRNA Co.,Ltd. (-7.75), greater than StemCell Institute Inc. (48.43), greater than GENOVA, Inc. (39.48), greater than Kohjin Bio Co., Ltd. (17.94), greater than Linical Co., Ltd. (-1.42), greater than Kidswell Bio Corporation (-17.75),
| Company | PE Ratio | Market cap |
|---|---|---|
| -13.73 | $11.35B | |
| -5.51 | $6.97B | |
| -5.72 | $10.34B | |
| -5.05 | $5.08B | |
| -7.75 | $8.32B | |
| 48.43 | $7.43B | |
| 39.48 | $10.87B | |
| 17.94 | $4.50B | |
| -1.42 | $4.74B | |
| -17.75 | $7.30B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like CellSource Co., Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like CellSource Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is CellSource Co., Ltd.'s PE Ratio?
How is the PE Ratio calculated for CellSource Co., Ltd. (4880.T)?
What is the highest PE Ratio for CellSource Co., Ltd. (4880.T)?
What is the 3-year average PE Ratio for CellSource Co., Ltd. (4880.T)?
What is the 5-year average PE Ratio for CellSource Co., Ltd. (4880.T)?
How does the current PE Ratio for CellSource Co., Ltd. (4880.T) compare to its historical average?